Expression of human NAA11 (ARD1B) gene is tissue-specific and is regulated by DNA methylation

Epigenetics

Volumn 6, Issue 11, 2011, Pages 1391-1399

  Pang, Alan L Y ^a   Clark, Jessica ^a   Chan, Wai Yee ^a,b   Rennert, Owen M ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

Arrest defective 1; CpG island methylation; Methylation specific polymerase chain reaction; N( ) acetyltransferase; Placenta; Promoter assay; Retrogene; Spermatogenesis; Testis

Indexed keywords

ACYLTRANSFERASE; BISULFITE; GENOMIC DNA; N(ALPHA) ACETYLTRANSFERASE 11 NATA CATALYTIC SUBUNIT; UNCLASSIFIED DRUG;

ARTICLE; CANCER TISSUE; CELL STRAIN HEK293; CPG ISLAND; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION; GENE LOCATION; GENE REPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR CLONING; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION;

EUKARYOTA; MAMMALIA;

EID: 81055138970     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.6.11.18125     Document Type: Article

References (37)

1. Yang XJ. Lysine acetylation and the bromodomain: a new partnership for signaling. Bioessays 2004; 26:1076-87.
2. Driessen HP, de Jong WW, Tesser GI, Bloemendal H. The mechanism of N-terminal acetylation of proteins. CRC Crit Rev Biochem 1985; 18:281-325.
3. Starheim KK, Gromyko D, Velde R, Varhaug JE, Arnesen T. Composition and biological significance of the human Nalpha-terminal acetyltransferases. BMC Proc 2009; 3:3.
4. Gautschi M, Just S, Mun A, Ross S, Rucknagel P, Dubaquie Y, et al. The yeast N(alpha)-acetyltransferase NatA is quantitatively anchored to the ribosome and interacts with nascent polypeptides. Mol Cell Biol 2003; 23:7403-14.
5. Polevoda B, Brown S, Cardillo TS, Rigby S, Sherman F. Yeast N(alpha)-terminal acetyltransferases are associated with ribosomes. J Cell Biochem 2008; 103:492-508.
6. Park EC, Szostak JW. ARD1 and NAT1 proteins form a complex that has N-terminal acetyltransferase activity. EMBO J 1992; 11:2087-93.
7. Arnesen T, Gromyko D, Kagabo D, Betts MJ, Starheim KK, Varhaug JE, et al. A novel human NatA Nalpha-terminal acetyltransferase complex: hNaa16p-hNaa10p (hNat2-hArd1). BMC Biochem 2009; 10:15.
8. Arnesen T, Van Damme P, Polevoda B, Helsens K, Evjenth R, Colaert N, et al. Proteomics analyses reveal the evolutionary conservation and divergence of N-terminal acetyltransferases from yeast and humans. Proc Natl Acad Sci USA 2009; 106:8157-62.
9. Hwang CS, Shemorry A, Varshavsky A. N-terminal acetylation of cellular proteins creates specific degradation signals. Science 327:973-7.
10. Forte GMA, Pool, Martin R, Stirling, Colin J. N-Terminal Acetylation Inhibits Protein Targeting to the Endoplasmic Reticulum. PLoS Biol 2011; 9:1001073.
11. Ohkawa N, Sugisaki S, Tokunaga E, Fujitani K, Hayasaka T, Setou M, et al. N-acetyltransferase ARD1-NAT1 regulates neuronal dendritic development. Genes Cells 2008; 13:1171-83.
12. Sugiura N, Adams SM, Corriveau RA. An evolutionarily conserved N-terminal acetyltransferase complex associated with neuronal development. J Biol Chem 2003; 278:40113-20.
13. Arnesen T, Gromyko D, Pendino F, Ryningen A, Varhaug JE, Lillehaug JR. Induction of apoptosis in human cells by RNAi-mediated knockdown of hARD1 and NATH, components of the protein N-alpha-acetyltransferase complex. Oncogene 2006; 25:4350-60.
14. Seo JH, Cha JH, Park JH, Jeong CH, Park ZY, Lee HS, et al. Arrest defective 1 autoacetylation is a critical step in its ability to stimulate cancer cell proliferation. Cancer Res 2010; 70:4422-32.
15. Lim JH, Park JW, Chun YS. Human arrest defective 1 acetylates and activates beta-catenin, promoting lung cancer cell proliferation. Cancer Res 2006; 66:10677-82.
16. Yu M, Ma M, Huang C, Yang H, Lai J, Yan S, et al. Correlation of expression of human arrest-defective-1 (hARD1) protein with breast cancer. Cancer Invest 2009; 27:978-83.
17. Fisher TS, Etages SD, Hayes L, Crimin K, Li B. Analysis of ARD1 function in hypoxia response using retroviral RNA interference. J Biol Chem 2005; 280:17749-57.
18. Yu M, Gong J, Ma M, Yang H, Lai J, Wu H, et al. Immunohistochemical analysis of human arrest-defective-1 expressed in cancers in vivo. Oncol Rep 2009; 21:909-15.
19. Jiang B, Ren T, Dong B, Qu L, Jin G, Li J, et al. Peptide mimic isolated by autoantibody reveals human arrest defective 1 overexpression is associated with poor prognosis for colon cancer patients. Am J Pathol 2010; 177:1095-103.
20. Ren T, Jiang B, Jin G, Li J, Dong B, Zhang J, et al. Generation of novel monoclonal antibodies and their application for detecting ARD1 expression in colorectal cancer. Cancer Lett 2008; 264:83-92.
21. Lee CF, Ou DS, Lee SB, Chang LH, Lin RK, Li YS, et al. hNaa10p contributes to tumorigenesis by facilitating DNMT1-mediated tumor suppressor gene silencing. J Clin Invest 2010; 120:2920-30.
22. Shin DH, Chun YS, Lee KH, Shin HW, Park JW. Arrest defective-1 controls tumor cell behavior by acetylating myosin light chain kinase. PLoS One 2009; 4:7451.
23. Kuo HP, Lee DF, Chen CT, Liu M, Chou CK, Lee HJ, et al. ARD1 stabilization of TSC2 suppresses tumorigenesis through the mTOR signaling pathway. Sci Signal 2010; 3:9.
24. Arnesen T, Gromyko D, Horvli O, Fluge O, Lillehaug J, Varhaug JE. Expression of N-acetyl transferase human and human Arrest defective 1 proteins in thyroid neoplasms. Thyroid 2005; 15:1131-6.
25. Hua KT, Tan CT, Johansson G, Lee JM, Yang PW, Lu HY, et al. N-alpha-acetyltransferase 10 protein suppresses cancer cell metastasis by binding PIX proteins and inhibiting Cdc42/Rac1 activity. Cancer Cell 2011; 19:218-31.
26. Pang AL, Peacock S, Johnson W, Bear DH, Rennert OM, Chan WY. Cloning, characterization and expression analysis of the novel acetyltransferase retrogene Ard1b in the mouse. Biol Reprod 2009; 81:302-9.
27. Jeong JW, Bae MK, Ahn MY, Kim SH, Sohn TK, Bae MH, et al. Regulation and destabilization of HIF-1alpha by ARD1-mediated acetylation. Cell 2002; 111:709-20.
28. Arnesen T, Betts MJ, Pendino F, Liberles DA, Anderson D, Caro J, et al. Characterization of hARD2, a processed hARD1 gene duplicate, encoding a human protein N-alpha-acetyltransferase. BMC Biochem 2006; 7:13.
29. Huang GL, Li BK, Zhang MY, Zhang HZ, Wei RR, Yuan YF, et al. LOH analysis of genes around D4S2964 identifies ARD1B as a prognostic predictor of hepatocellular carcinoma. World J Gastroenterol 2010; 16:2046-54.
30. Illingworth RS, Bird AP. CpG islands-'a rough guide'. FEBS Lett 2009; 583:1713-20.
31. Berdasco M, Esteller M. Aberrant epigenetic landscape in cancer: how cellular identity goes awry. Dev Cell 2010; 19:698-711.
32. Klose RJ, Bird AP. Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci 2006; 31:89-97.
33. Portela A, Esteller M. Epigenetic modifications and human disease. Nat Biotechnol 2010; 28:1057-68.
34. Iannello RC, Young J, Sumarsono S, Tymms MJ, Dahl HH, Gould J, et al. Regulation of Pdha-2 expression is mediated by proximal promoter sequences and CpG methylation. Mol Cell Biol 1997; 17:612-9.
35. Tang H, Goldberg E. Homo sapiens lactate dehydrogenasec (Ldhc) gene expression in cancer cells is regulated by transcription factor Sp1, CREB and CpG island methylation. J Androl 2009; 30:157-67.
36. De Smet C, Lurquin C, Lethe B, Martelange V, Boon T. DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter. Mol Cell Biol 1999; 19:7327-35.
37. Li LC, Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics 2002; 18:1427-31.